Status:
WITHDRAWN
Liposomal Bupivacaine vs Standard Penile Block for Hypospadias Repair
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Hypospadias
Eligibility:
MALE
6-24 years
Phase:
PHASE1
Brief Summary
The investigator proposes a prospective randomized study of males with hypospadias to either bupivacaine penile block or liposomal bupivacaine block for hypospadias repair, Figure 3. The investigator ...
Detailed Description
Male patients who are greater than 6 months of age will be enrolled in the study prior to elective outpatient hypospadias repair with ASA class 1-2. For a male who meets the inclusion criteria, after ...
Eligibility Criteria
Inclusion
- Males aged 6 months to 24 months of all races and ethnicities that have hypospadias requiring surgical intervention and post-operative urethral catheterization.
Exclusion
- Males who are not age 6 mo. to 24 months, those who do not have a diagnosis of hypospadias, those who have an ASA class of 3 or greater or known liver or renal impairment, or who have an allergy to local anesthetics such as lidocaine, bupivacaine, etc.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04479371
Start Date
July 1 2021
End Date
July 30 2023
Last Update
August 16 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.